Clinical trial Recruiting at 1 site Observational Ages 1 Year to 18

Transcutaneous versus blood CO2 monitoring in critically ill children

Official title: Comparison of Transcutaneous Carbon Dioxide Monitoring With Arterialized or Arterial Blood Gas Analysis in PICU

Run by Brno University Hospital · NCT07468006 · Data updated 2026-11-12

This project tests whether noninvasive transcutaneous CO2 monitoring gives similar results to arterial blood gas CO2 measurements in children aged 1–18 with respiratory insufficiency in the pediatric ICU, including those on vasopressors.

More Respiratory Insufficiency trials

Quick facts

Study typeObservational
Ages1 Year to 18 Years
SexAll
Enrollment20 (estimated)
SponsorBrno University Hospital
Academic / other
Locations1 site (Brno)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 31, 2027
Study endsJanuary 31, 2028
Registry record updatedMarch 12, 2026
Trial IDNCT07468006 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 1–18 admitted to the PICU with respiratory insufficiency who are expected to need more than one arterialized capillary or arterial blood gas sample, including those receiving vasopressor support.

Probably not a fit

Patients with repeated sensor adhesion failure, hypothermia (<35 °C), large recent tPCO2 variability, or non‑physiological tPCO2 values are unlikely to benefit from transcutaneous monitoring in this context.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study in a pediatric intensive care unit comparing paired transcutaneous CO2 (tPCO2) readings with arterialized or arterial blood gas PaCO2 values in children aged 1–18 with respiratory insufficiency. Paired measurements will be analyzed using Bland–Altman methods with correction for repeated measures to quantify agreement. Subgroup analyses will examine the effect of vasopressor therapy and peripheral perfusion on tPCO2 accuracy, and secondary analyses will compare transcutaneous and arterial oxygen measurements (tPO2 vs PaO2). The goal is to define when transcutaneous capnometry can be used reliably and what its limitations are in critically ill pediatric patients.

Why it matters

Potential benefit: If successful, reliable transcutaneous CO2 monitoring could reduce painful arterial blood draws and provide continuous real‑time ventilation information for critically ill children.

How similar studies have gone: Previous adult and neonatal work has shown reasonable correlation for transcutaneous capnometry in stable settings, but accuracy is known to decline with poor perfusion or vasopressor use and is less well validated in critically ill pediatric patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 1-18 years
* Diagnosis of respiratory insufficiency or impaired peripheral perfusion
* Expected need for more than one arterialized capillary or arterial blood gas sample
* Admission to PICU

Exclusion Criteria:

* Repeated failure of sensor adhesion
* Hypothermia \< 35 °C
* Time difference \> ±5 minutes between tPCO₂ and blood sampling
* Large tPCO₂ variability (\> ±1 kPa) in 15 minutes preceding blood sampling
* Non-physiological tPCO₂ values incompatible with life

Where it's running

  • University Hospital Brno
    Brno, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.